ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
2,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,2,Headache,Headaches NEC,Headaches,Nerv,N
6,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
12,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
16,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
21,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
23,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
23,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
24,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
24,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Prothrombin level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
29,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
29,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
31,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
33,2,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
34,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
34,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,3,Headache,Headaches NEC,Headaches,Nerv,N
35,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,2,Headache,Headaches NEC,Headaches,Nerv,N
35,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
36,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
37,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
38,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
38,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
38,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
38,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Headache,Headaches NEC,Headaches,Nerv,N
40,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
40,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
43,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
43,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
44,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
45,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
46,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
47,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
47,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
48,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
49,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
50,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
52,1,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
53,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
54,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
54,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
55,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
57,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
57,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
57,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
58,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
58,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
58,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
63,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
64,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
65,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
66,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
66,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
67,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
67,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
